Stockreport

Edesa Biotech (EDSA) Reaffirms 2026 Clinical Study Timeline for Vitiligo Treatment [Yahoo! Finance]

Edesa Biotech, Inc. - Common Shares  (EDSA) 
PDF Edesa Biotech Inc. (NASDAQ: EDSA ) is one of the unstoppable stocks that could double your money. On March 26, Edesa reaffirmed that enrollment for its Phase 2 clinical [Read more]